Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

Clinical trial NCT03668639 · UNKNOWN

Trial details

NCT number: NCT03668639
Sponsor: Christina Ruhlmann
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting Adverse Event Cervical Cancer

Start date: 2018-09-05
Primary completion: 2023-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.